| 2007-12-11 |
CASI pharmaceuticals, Inc. |
EntreMed Announces FDA Acceptance of IND Application for Panzem(R) in Rheumatoid Arthritis issuerdirect.com ↗ |
| 2007-10-24 |
CASI pharmaceuticals, Inc. |
EntreMed Presents Results for Panzem(R) NCD Phase 2 Ovarian Cancer Study issuerdirect.com ↗ |
| 2007-07-11 |
CASI pharmaceuticals, Inc. |
EntreMed to Collaborate with University of New South Wales on Panzem(R) Mechanisms issuerdirect.com ↗ |
| 2007-06-06 |
CASI pharmaceuticals, Inc. |
Clinical Results From EntreMed's Panzem(R) NCD and Taxol(R) Breast Cancer Study Presented at ASCO issuerdirect.com ↗ |
| 2007-06-05 |
CASI pharmaceuticals, Inc. |
Phase 2 Results for EntreMed's Panzem(R) NCD Brain Cancer Study Presented at ASCO issuerdirect.com ↗ |
| 2007-06-04 |
CASI pharmaceuticals, Inc. |
EntreMed Presents Phase 2 Results for Panzem(R) Capsules in Multiple Myeloma issuerdirect.com ↗ |
| 2007-05-29 |
CASI pharmaceuticals, Inc. |
EntreMed Commences Phase 2 Clinical Trial Combining Panzem(R) NCD and Temodar(R) in Brain Cancer Patients issuerdirect.com ↗ |
| 2007-03-06 |
CASI pharmaceuticals, Inc. |
EntreMed Commences Panzem(R) NCD Phase 2 Clinical Trial in Renal Cell Cancer issuerdirect.com ↗ |
| 2006-12-21 |
CASI pharmaceuticals, Inc. |
EntreMed's Panzem(R) Demonstrates Antitumor Activity in Brain Tumor Model issuerdirect.com ↗ |
| 2006-12-12 |
CASI pharmaceuticals, Inc. |
EntreMed Presents Data on the Combination of Panzem(R) and Velcade(R) in Multiple Myeloma issuerdirect.com ↗ |
| 2006-10-31 |
CASI pharmaceuticals, Inc. |
EntreMed Commences Phase 2 Clinical Trial With Panzem(R) NCD in Ovarian Cancer issuerdirect.com ↗ |
| 2006-06-28 |
CASI pharmaceuticals, Inc. |
EntreMed Granted Orphan Drug Designation for Panzem(R) (2ME2) In Glioblastoma issuerdirect.com ↗ |
| 2006-05-15 |
CASI pharmaceuticals, Inc. |
EntreMed Initiates Combination Phase 2 Clinical Trial With Panzem(R) NCD in Carcinoid Cancer issuerdirect.com ↗ |
| 2006-04-25 |
CASI pharmaceuticals, Inc. |
EntreMed's Panzem(R) NCD Enters Clinical Trial in Metastatic Breast Cancer issuerdirect.com ↗ |
| 2006-04-03 |
CASI pharmaceuticals, Inc. |
EntreMed Presents Preclinical Results at AACR for Panzem(R) and ENMD-1198 issuerdirect.com ↗ |
| 2006-01-19 |
CASI pharmaceuticals, Inc. |
EntreMed Commences Phase 2 Studies with Panzem(R) NCD issuerdirect.com ↗ |
| 2005-11-16 |
CASI pharmaceuticals, Inc. |
EntreMed Presents Panzem(R) NCD Phase Ib Clinical Trial Results issuerdirect.com ↗ |
| 2005-09-27 |
CASI pharmaceuticals, Inc. |
Panzem(R) Demonstrates Safety and Clinical Benefit in Hormone Refractory Prostate Cancer issuerdirect.com ↗ |
| 2005-06-29 |
CASI pharmaceuticals, Inc. |
Duke University Awarded Susan G. Komen Grant to Evaluate EntreMed's Panzem(R) NCD in Breast Cancer issuerdirect.com ↗ |
| 2005-04-14 |
CASI pharmaceuticals, Inc. |
EntreMed Granted FDA Orphan Drug Status for Panzem(R) (2ME2) in Ovarian Cancer issuerdirect.com ↗ |
|